News

Latest news from the biobanking and life sciences industry. Publish Your News Release Here

Scleroderma Research Foundation To Build “CONQUER” Database And Biorepository – Partners With Major Medical...

The Scleroderma Research Foundation (SRF) is a non-profit, 501(c)(3) organization based in San Francisco. The SRF mission is to fund and facilitate the most promising, highest quality research aimed at improved therapies and, ultimately, a cure for scleroderma. The...

How Do People In Nashville React To The Biobank Consent Process?

Gathering informed consent from participants is a pillar of biobanking. As ambitious biobanking projects such as All of US and UK biobank proliferate and become ever larger, the benefits and the potential risks for participants also grow....

ContextVision’s Digital Pathology Continues To Move Forward Based On Rigorous R&D

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, continued to advance its artificial intelligence portfolio in the second quarter 2019. The company’s AI-based product Altumira™ for X-ray is now commercially available and INIFY Prostate for digital...

LakePharma’s cGMP Plasmid MicroBiomanufacturing Center Is Now Operational

LakePharma Inc., the leading US-based biologics company specializing in antibody & protein engineering, cell line development, and protein production, has announced that their cGMP microBiomanufacturing™ Center is now commercially manufacturing plasmid DNA at their Hopkinton, MA location, which is in close...

Glucosamine Supplementation Reduced Risk Of Mortality In The UK Biobank

In people glucosamine (C6H13NO5) is a precursor in the synthesis of glycosylated proteins, such as may be found in cartilage, and lipids. Glucosamine is also part of the structure of the polysaccharides chitosan and chitin, derived from...

Multinational Kids-DOTT Trial Of Anticoagulant Therapy For Venous Thromboembolism

Enrollment has completed for a landmark randomized clinical trial at Johns Hopkins All Children’s on the duration of anti-clotting medication (anticoagulant) therapy for venous thromboembolism (VTE) in patients under 21 years old — the Kids-DOTT trial. A multinational biobank of...

Predictive Laboratories Hits The 200 Participant Milestone In Their Chronic Pain Study

Predictive Technology Group, Inc., a leader in the use of data analytics for disease identification and subsequent precision therapeutic intervention, has announced that its wholly owned subsidiary Predictive Laboratories has reached an enrollment milestone of 200 participants in its...

FDA Grants RMAT Designation To Cellerant’s “Off-The-Shelf” Romyelocel-L Cell Therapy

Cellerant Therapeutics Inc., is a clinical-stage company developing innovative cell and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s romyelocel-L (human myeloid progenitor cells) “off-the-shelf” cell therapy does not require HLA matching and is designed to prevent...

The Institute For In Vitro Sciences Secures New Equipment Via RIFM Grant

The Institute for In Vitro Sciences, Inc. (IIVS) has received a grant from the Research Institute for Fragrance Materials (RIFM) to support its mission to promote non-animal methods. The grant will be used to purchase equipment that will enable IIVS...

AmnioFix® Injectable Granted RMAT Designation By The FDA For The Treatment Of Osteoarthritis Of...

MiMedx Group, Inc. developed the proprietary PURION® Process that separates placental tissues collected after birth, cleans and reassembles layers, and then dehydrates the tissue for long term storage under sterile conditions. The PURION® Process removes free blood while retaining...

🔉 Stay Connected

947FollowersFollow

🔥 Most Popular



Featured Vendors
X